Figure 2 | Gene Therapy

Figure 2

From: Erratum: Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

Figure 2

Muscle perfusion imaged by contrast pulse sequence (CPS) ultrasound technique in normal muscles (a–d) and after ischemia operation (eh). Native image after AAV-VEGF-A-A165 injection, asterisk indicates the location of the injection (a). CPS images from the same muscle 1 month (b) and 12 months (d) after AAV-VEGF-A-A165 gene transfer. Power Doppler image after AAV-VEGF-A-A165 gene transfer (c). Power Doppler (e) and CPS (f) images 6 months after ischemia operation and AAV-LacZ gene transfer. Power Doppler (g) and CPS (h) images 6 months after ischemia operation and AAV-VEGF-A-A165 gene transfer. Arrowheads in Doppler images indicate the signal from large vessels. Perfusion ratio to contralateral intact in normal muscles (i) and in ischemic muscles (j). Perfusion in VEGF-A-transduced muscle was increased compared with LacZ muscle already 1 week after gene transfer both in normoxic and in ischemic muscles. Results are presented as means±s.e.m., *P0.05, n=3.

Back to article page